⌘K
OverviewStock screenerAnalyst actionsCalendar
MarketsInvestorsSign in
StockUnited StatesNasdaqCM

LQDA

Liquidia Corporation

Healthcare · Drug Manufacturers - Specialty & Generic

69.12USD

+1.4400 (+2.13%)

DescriptionHistoricalFinancialsRelative ValueResearchNewsDiscussionOptionsPrice Chart ↗Fundamental Chart ↗

Fetching financial statements from SEC filings…

In $M except per-shareQ2 FY26Q1 FY26Q4 FY25*Q3 FY25Q2 FY25Q1 FY25Q4 FY24*Q3 FY24
Revenue17213392549334
Cost of Revenue—————212
Gross Profit—————223
Operating Income8662202-38-35-36-29
Net Income755315-4-42-38-39-31
EPS (Diluted)$0.74$0.52$0.17$-0.04$-0.49$-0.45$-0.46$-0.40

* Derived period (computed from FY minus reported quarters). Source: SEC filings (EDGAR)